Vericel Corporation (VCEL)

Jan 15, 2025, 8:52 AM EST - 3 days ago

Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

APLD CVGW

Jan 14, 2025, 4:05 PM EST - 3 days ago

Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets

Dec 19, 2024, 12:50 PM EST - 4 weeks ago

Vericel Corporation: Hard To Justify Current Valuation

Nov 7, 2024, 1:52 PM EST - 2 months ago

Vericel Corporation (VCEL) Q3 2024 Earnings Conference Call Transcript

Nov 7, 2024, 7:55 AM EST - 2 months ago

Vericel Reports Third Quarter 2024 Financial Results

Oct 24, 2024, 8:30 AM EDT - 3 months ago

Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024

Aug 29, 2024, 9:17 AM EDT - 5 months ago

Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024

Aug 26, 2024, 7:45 AM EDT - 5 months ago

Vericel Announces FDA Approval and Commercial Availability of MACI Arthro

Aug 15, 2024, 4:05 PM EDT - 5 months ago

Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns

Aug 7, 2024, 8:30 AM EDT - 5 months ago

Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024

Aug 1, 2024, 3:58 PM EDT - 6 months ago

Vericel Corporation (VCEL) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 7:55 AM EDT - 6 months ago

Vericel Reports Second Quarter 2024 Financial Results

Jul 22, 2024, 8:30 AM EDT - 6 months ago

Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer

Jul 18, 2024, 8:30 AM EDT - 6 months ago

Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024

Jun 11, 2024, 8:30 AM EDT - 7 months ago

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024

May 22, 2024, 8:30 AM EDT - 8 months ago

Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024

May 8, 2024, 2:36 PM EDT - 9 months ago

Vericel Corporation (VCEL) Q1 2024 Earnings Call Transcript

May 8, 2024, 7:55 AM EDT - 9 months ago

Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance

Apr 24, 2024, 8:30 AM EDT - 9 months ago

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

Feb 29, 2024, 11:39 AM EST - 11 months ago

Vericel Corporation (VCEL) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 7:55 AM EST - 11 months ago

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

Feb 27, 2024, 8:30 AM EST - 11 months ago

Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024

Feb 15, 2024, 8:30 AM EST - 1 year ago

Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024

Feb 5, 2024, 8:30 AM EST - 1 year ago

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Jan 9, 2024, 7:55 AM EST - 1 year ago

Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

Jan 3, 2024, 8:30 AM EST - 1 year ago

Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024

Nov 8, 2023, 2:43 PM EST - 1 year ago

Vericel Corporation (VCEL) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 7:55 AM EST - 1 year ago

Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Nov 7, 2023, 8:30 AM EST - 1 year ago

Vericel to Present at the Stephens Annual Investment Conference

Oct 25, 2023, 8:30 AM EDT - 1 year ago

Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023

Sep 28, 2023, 8:30 AM EDT - 1 year ago

Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid

Sep 20, 2023, 4:30 PM EDT - 1 year ago

Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults

Sep 6, 2023, 8:30 AM EDT - 1 year ago

Vericel to Present at the Morgan Stanley Global Healthcare Conference

Aug 2, 2023, 7:55 AM EDT - 1 year ago

Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Jul 20, 2023, 8:30 AM EDT - 1 year ago

Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023

Jun 27, 2023, 10:57 PM EDT - 1 year ago

Vericel: Multiyear Growth Catalysts, Proprietary Solutions Will Drive Market Cap Expansion

May 10, 2023, 11:34 AM EDT - 1 year ago

Vericel Corporation (VCEL) Q1 2023 Earnings Call Transcript

May 10, 2023, 7:55 AM EDT - 1 year ago

Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

May 2, 2023, 9:00 AM EDT - 1 year ago

Dimension Inx announces the addition of biotech industry leaders Paul K. Wotton, Ph.D.

Apr 26, 2023, 8:30 AM EDT - 1 year ago

Vericel to Report First-Quarter 2023 Financial Results on May 10, 2023

Apr 2, 2023, 9:14 AM EDT - 1 year ago

Vericel Corporation: A Promising Future In Advanced Cell Therapies

Feb 28, 2023, 8:30 AM EST - 2 years ago

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 7, 2023

Feb 23, 2023, 2:55 PM EST - 2 years ago

Vericel Corporation (VCEL) Q4 2022 Earnings Call Transcript

Feb 23, 2023, 7:55 AM EST - 2 years ago

Vericel Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Full-Year 2023 Financial Guidance

Feb 9, 2023, 8:00 AM EST - 2 years ago

Vericel to Report Fourth-Quarter 2022 Financial Results on February 23, 2023

Jan 10, 2023, 7:55 AM EST - 2 years ago

Vericel Announces Preliminary Fourth-Quarter and Full-Year 2022 Financial Results and Accelerated Launch Timeline for MACI Arthroscopic Program

Jan 5, 2023, 9:00 AM EST - 2 years ago

Kytopen Appoints Paul K. Wotton, Ph.D.

Jan 4, 2023, 8:34 AM EST - 2 years ago

Vericel to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023

Jan 1, 2023, 6:00 AM EST - 2 years ago

Vericel: Aggressive Growth In 2023

Dec 29, 2022, 1:45 PM EST - 2 years ago

Vericel Announces FDA Approval of NexoBrid for the Treatment of Severe Thermal Burns in Adults